P38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents

Cancer Letters

Volumn 344, Issue 2, 2014, Pages 174-179

  Sui, Xinbing ^a,b   Kong, Na ^a,b   Ye, Li ^a   Han, Weidong ^a,b   Zhou, Jichun ^a   Zhang, Qin ^c   He, Chao ^a,b   Pan, Hongming ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b Biomedical Research Center and Key Laboratory of Biotherapy of Zhejiang Province   (China)

^c ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Apoptosis; Autophagy; Chemoresistance; JNK; P38

Indexed keywords

ALPHA TOCOPHEROL; ANTHOCYANIN; ANTINEOPLASTIC AGENT; CERAMIDE; CYCLOPHOSPHAMIDE; MAPATUMUMAB; MITOGEN ACTIVATED PROTEIN KINASE P38; OXALIPLATIN; PACLITAXEL; STRESS ACTIVATED PROTEIN KINASE; TOPOTECAN;

APOPTOSIS; AUTOPHAGY; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; DRUG RESPONSE; DRUG SENSITIVITY; GENOTOXICITY; HUMAN; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; STRESS;

APOPTOSIS; AUTOPHAGY; CHEMORESISTANCE; JNK; P38;

ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; HUMANS; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; NEOPLASMS; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 84893692276     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.11.019     Document Type: Review

References (93)

1. Khavari T.A., Rinn J. Ras/Erk MAPK signaling in epidermal homeostasis and neoplasia. Cell Cycle. 2007, 6:2928-2931.
2. Hommes D.W., Peppelenbosch M.P., van Deventer S.J. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 2003, 52:144-151.
3. Schaeffer H.J., Weber M.J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 1999, 19:2435-2444.
4. Keyse S.M. Protein phosphatases and the regulation of mitogen-activated protein kinase signaling. Curr. Opin. Cell. Biol. 2000, 12:186-192.
5. Kyriakis J.M., Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol. Rev. 2012, 92:689-737.
6. Yang S.H., Sharrocks A.D., Whitmarsh A.J. MAP kinase signalling cascades and transcriptional regulation. Gene 2013, 513:1-13.
7. Olsen B.B., Svenstrup T.H., Guerra B. Downregulation of protein kinase CK2 induces autophagic cell death through modulation of the mTOR and MAPK signaling pathways in human glioblastoma cells. Int. J. Oncol. 2012, 41:1967-1976.
8. Fang J.Y., Richardson B.C. The MAPK signalling pathways and colorectal cancer. Lancet Oncol. 2005, 6:322-327.
9. Rosenfeldt M.T., Ryan K.M. The role of autophagy in tumor development and cancer therapy. Exp. Rev. Mol. Med. 2009, 11:e36.
10. Kondo Y., Kanzawa T., Sawaya R., Kondo S. The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer 2005, 5:726-734.
11. Maycotte P., Thorburn A. Autophagy and cancer therapy. Cancer Biol. Ther. 2011, 1:127-137.
12. Janku F., McConkey D.J., Hong D.S., Kurzrock R. Autophagy as a target for anticancer therapy. Nat. Rev. Clin. Oncol. 2011, 8:528-539.
13. Han J., Lee J.D., Bibbs L., Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994, 265:808-811.
14. Loesch M., Chen G. The p38 MAPK stress pathway as a tumor suppressor or more?. Front Biosci. 2008, 13:3581-3593.
15. Ono K., Han J. The p38 signal transduction pathway: activation and function. Cell. Signal. 2000, 12:1-13.
16. Cuenda A., Rousseau S. P38 MAP-kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 2007, 1773:1358-1375.
17. Brancho D., Tanaka N., Jaeschke A., Ventura J.J., Kelkar N., Tanaka Y., Kyuuma M., Takeshita T., Flavell R.A., Davis R.J. Mechanism of p38 MAP kinase activation in vivo. Genes Dev. 2003, 7:1969-1978.
18. Deacon K., Mistry P., Chernoff J., Blank J.L., Patel R. P38 Mitogen-activated protein kinase mediates cell death and p21-activated kinase mediates cell survival during chemotherapeutic drug-induced mitotic arrest. Mol. Biol. Cell. 2003, 14:2071-2087.
19. Cuadrado A., Nebreda A.R. Mechanisms and functions of p38 MAPK signalling. Biochem. J. 2010, 429:403-417.
20. Olson J.M., Hallahan A.R. P38 MAP kinase: a convergence point in cancer therapy. Trends Mol. Med. 2004, 10:125-129.
21. Pang H., Cai L., Yang Y., Chen X., Sui G., Zhao C. Knockdown of osteopontin chemosensitizes MDA-MB-231 cells to cyclophosphamide by enhancing apoptosis through activating p38 MAPK pathway. Cancer Biother. Radiopharm. 2011, 26:165-173.
22. Shin D.Y., Lee W.S., Lu J.N., Kang M.H., Ryu C.H., Kim G.Y., Kang H.S., Shin S.C., Choi Y.H. Induction of apoptosis in human colon cancer HCT-116 cells by anthocyanins through suppression of Akt and activation of p38-MAPK. Int. J. Oncol. 2009, 35:1499-1504.
23. Chiu S.J., Chao J.I., Lee Y.J., Hsu T.S. Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells. Toxicol. Lett. 2008, 179:63-70.
24. Lou X., Zhou Q., Yin Y., Zhou C., Shen Y. Inhibition of the met receptor tyrosine kinase signaling enhances the chemosensitivity of glioma cell lines to CDDP through activation of p38 MAPK pathway. Mol. Cancer Ther. 2009, 8:1126-1136.
25. Song H., Wohltmann M., Tan M., Bao S., Ladenson J.H., Turk J. Group VIA PLA2 (iPLA2β) is activated upstream of p38 mitogen-activated protein kinase (MAPK) in pancreatic islet β-cell signaling. J. Biol. Chem. 2012, 287:5528-5541.
26. Hallahan A.R., Pritchard J.I., Chandraratna R.A., Ellenbogen R.G., Geyer J.R., Overland R.P., Strand A.D., Tapscott S.J., Olson J.M. BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat. Med. 2003, 9:1033-1038.
27. Lim J.H., Woo S.M., Min K.J., Park E.J., Jang J.H., Seo B.R., Iqbal T., Lee T.J., Kim S.H., Choi Y.H., Kwon T.K. Rottlerin induces apoptosis of HT29 colon carcinoma cells through NAG-1 upregulation via an ERK and p38 MAPK-dependent and PKC δ-independent mechanism. Chem. Biol. Interact. 2012, 197:1-7.
28. Salim H., Akbar N.S., Zong D., Vaculova A.H., Lewensohn R., Moshfegh A., Viktorsson K., Zhivotovsky B. MiRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence. Br. J. Cancer 2012, 107:1361-1373.
29. Limami Y., Pinon A., Leger D.Y., Pinault E., Delage C., Beneytout J.L., Simon A., Liagre B. The P2Y2/Src/p38/COX-2 pathway is involved in the resistance to ursolic acid-induced apoptosis in colorectal and prostate cancer cells. Biochimie 2012, 94:1754-1763.
30. Chen S.F., Nieh S., Jao S.W., Liu C.L., Wu C.H., Chang Y.C., Yang C.Y., Lin Y.S. Quercetin suppresses drug-resistant spheres via the p38 MAPK-Hsp27 apoptotic pathway in oral cancer cells. PLoS One 2012, 7:e49275.
31. Gan L., Wang J., Xu H., Yang X. Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling. Prostate 2011, 71:1158-1166.
32. Cui Q., Tashiro S., Onodera S., Minami M., Ikejima T. Oridonininducedautophagyinhumancervical carcinomaHeLa cellsthrough Ras, JNK, and P38 regulation. J. Pharmacol. Sci. 2007, 105:317-325.
33. Hu C., Zou M.J., Zhao L., Lu N., Sun Y.J., Gou S.H., Xi T., Guo Q.L. E Platinum, a newly synthesized platinum compound, inducesautophagyvia inhibiting phosphorylation of mTOR in gastric carcinoma BGC-823 cells. Toxicol. Lett. 2012, 210:78-86.
34. Zhou C., Zhou J., Sheng F., Zhu H., Deng X., Xia B., Lin J. The heme oxygenase-1 inhibitor ZnPPIX induces non-canonical, Beclin 1-independent, autophagy through p38 MAPK pathway. Acta Biochim. Biophys. Sin. (Shanghai) 2012, 44:815-822.
35. Paillas S., Causse A., Marzi L., de Medina P., Poirot M., Denis V., Vezzio-Vie N., Espert L., Arzouk H., Coquelle A., Martineau P., Del Rio M., Pattingre S., Gongora C. MAPK14/p38α confers irinotecan resistance to TP53-defective cells by inducing survivalautophagy. Autophagy 2012, 8:1098-1112.
36. Ye Y.C., Yu L., Wang H.J., Tashiro S., Onodera S., Ikejima T. TNFα-induced necroptosis and autophagy via suppression of the p38-NF-κB survival pathway in L929 cells. J. Pharmacol. Sci. 2011, 117:160-169.
37. Thyagarajan A., Jedinak A., Nguyen H., Terry C., Baldridge L.A., Jiang J., Sliva D. Triterpenes from Ganoderma Lucidum induce autophagy in colon cancer through the inhibition of p38 mitogen-activated kinase (p38 MAPK). Nutr. Cancer 2010, 62:630-640.
38. Keil E., Höcker R., Schuster M., Essmann F., Ueffing N., Hoffman B., Liebermann D.A., Pfeffer K., Schulze-Osthoff K., Schmitz I. Phosphorylation of Atg5 by the Gadd45β-MEKK4-p38pathway inhibitsautophagy. Cell Death Differ. 2013, 20:321-332.
39. Webber J.L., Tooze S.A. Coordinated regulation of autophagy by p38alpha MAPK through mAtg9 and p38IP. EMBO J. 2010, 29:27-40.
40. Webber J.L. Regulation of autophagy by p38alpha MAPK. Autophagy 2010, 6:292-293.
41. Choi C.H., Lee B.H., Ahn S.G., Oh S.H. Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3β. Biochem. Biophys. Res. Commun. 2012, 418:759-764.
42. Chiacchiera F., Grossi V., Cappellari M., Peserico A., Simonatto M., Germani A., Russo S., Moyer M.P., Resta N., Murzilli S., Simone C. Blocking p38/ERK crosstalk affects colorectal cancer growth by inducing apoptosis in vitro and in preclinical mouse models. Cancer Lett. 2012, 324:98-108.
43. Comes F., Matrone A., Lastella P., Nico B., Susca F.C., Bagnulo R., Ingravallo G., Modica S., Lo Sasso G., Moschetta A., Guanti G., Simone C. GREat novel cell type-specific role of p38alpha in the control of autophagy and cell death in colorectal cancer cells. Cell Death Differ. 2007, 14:693-702.
44. Tiwari M., Kumar A., Sinha R.A., Shrivastava A., Balapure A.K., Sharma R., Bajpai V.K., Mitra K., Babu S., Godbole M.M. Mechanism of 4-HPR-induced apoptosis in glioma cells: evidences suggesting role of mitochondrial-mediated pathway and endoplasmic reticulum stress. Carcinogenesis 2006, 27:2047-2058.
45. Tiwari M., Bajpai V.K., Sahasrabuddhe A.A., Kumar A., Sinha R.A., Behari S., Godbole M.M. Inhibition of N-(4-hydroxyphenyl)retinamide-induced autophagy at a lower dose enhances cell death in malignant glioma cells. Carcinogenesis 2008, 29:600-609.
46. Králová V., Benešová S., Cervinka M., Rudolf E. Selenite-induced apoptosis and autophagy in colon cancer cells. Toxicol. In Vitro 2012, 26:258-268.
47. Simone C. Signal-dependent control of autophagy and cell death in colorectal cancer cell: the role of the p38 pathway. Autophagy 2007, 3:468-471.
48. Kim D.S., Kim J.H., Lee G.H., Kim H.T., Lim J.M., Chae S.W., Chae H.J., Kim H.R. P38 mitogen-activated protein kinase is involved in endoplasmic reticulum stress-induced cell death and autophagy in human gingival fibroblasts. Biol. Pharm. Bull. 2010, 33:545-549.
49. Lv X.C., Zhou H.Y. Resveratrol protects H9c2 embryonic rat heart derived cells fromoxidative stressby inducingautophagy: role of p38 mitogen-activated protein kinase. Can. J. Physiol. Pharmacol. 2012, 90:655-662.
50. Dolado I., Swat A., Ajenjo N., De Vita G., Cuadrado A., Nebreda A.R. P38alpha MAP kinaseas asensorofreactive oxygen speciesintumorigenesis. Cancer Cell. 2007, 11:191-205.
51. de la Cruz-Morcillo M.A., Valero M.L., Callejas-Valera J.L., Arias-González L., Melgar-Rojas P., Galán-Moya E.M., García-Gil E., García-Cano J., Sánchez-Prieto R. P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance. Oncogene 2012, 31:1073-1085.
52. Cruz-Morcillo M.A., Sánchez-Prieto R. Autop38-phagy and apop38-tosis in genotoxic stress: a strange duo. Autophagy 2012, 8:135-137.
53. Chiacchiera F., Matrone A., Ferrari E., Ingravallo G., Lo Sasso G., Murzilli S., Petruzzelli M., Salvatore L., Moschetta A., Simone C. p38Alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-dependent transcription. Cell Death Differ. 2009, 16:1203-1214.
54. Paillas S., Boissière F., Bibeau F., Denouel A., Mollevi C., Causse A., Denis V., Vezzio-Vié N., Marzi L., Cortijo C., Ait-Arsa I., Askari N., Pourquier P., Martineau P., Del Rio M., Gongora C. Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma. Cancer Res. 2011, 71:1041-1049.
55. Zhan Y., Gong K., Chen C., Wang H., Li W. P38 MAP kinase functions as a switch in MS-275-induced reactive oxygen species-dependent autophagy and apoptosis in human colon cancer cells. Free Radic. Biol. Med. 2012, 53:532-543.
56. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., Avruch J., Woodgett J.R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994, 369:156-160.
57. Pulverer B.J., Kyriakis J.M., Avruch J., Nikolakaki E., Woodgett J.R. Phosphorylation of c-jun mediated by MAP kinases. Nature 1991, 353:670-674.
58. Yang D.D., Kuan C.Y., Whitmarsh A.J., Rincón M., Zheng T.S., Davis R.J., Rakic P., Flavell R.A. Absence of excito toxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 1997, 389:865-870.
59. Fleming Y., Armstrong C.G., Morrice N., Paterson A., Goedert M., Cohen P. Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7. Biochem. J. 2000, 352:145-154.
60. Johnson G.L., Nakamura K. The c-jun kinase/stress-activated pathway: regulation, function and role in human disease. Biochim. Biophys. Acta 2007, 1773:1341-1348.
61. Cui J., Zhang M., Zhang Y.Q., Xu Z.H. JNK pathway: diseases and therapeutic potential. Acta Pharmacol. Sin. 2007, 28:601-608.
62. Sabapathy K. Role of theJNKpathway in human diseases. Prog. Mol. Biol. Transl. Sci. 2012, 106:145-169.
63. Malilas W., Koh S.S., Srisuttee R., Boonying W., Cho I.R., Jeong C.S., Johnston R.N., Chung Y.H. Cancer upregulated gene 2, a novel oncogene, confers resistance to oncolytic vesicular stomatitis virus through STAT1-OASL2 signaling. Cancer Gene. Ther. 2013, 20:125-132.
64. Xiao F., Liu B., Zhu Q.X. c-Jun N-terminal kinase is required for thermotherapy-induced apoptosis in human gastric cancer cells. World J. Gastroenterol. 2012, 18:7348-7356.
65. Song I.S., Jun S.Y., Na H.J., Kim H.T., Jung S.Y., Ha G.H., Park Y.H., Long L.Z., Yu D.Y., Kim J.M., Kim J.H., Ko J.H., Kim C.H., Kim N.S. Inhibition of MKK7-JNKby the TOR signaling pathway regulator-like protein contributes to resistance of HCC cells to TRAIL-inducedapoptosis. Gastroenterology 2012, 143:1341-1351.
66. Sau A., Filomeni G., Pezzola S., D'Aguanno S., Tregno F.P., Urbani A., Serra M., Pasello M., Picci P., Federici G., Caccuri A.M. Targeting GSTP1-1 inducesJNKactivation and leads toapoptosisin cisplatin-sensitive and -resistant human osteosarcoma cell lines. Mol. Biosyst. 2012, 8:994-1006.
67. Tang R.X., Kong F.Y., Fan B.F., Liu X.M., You H.J., Zhang P., Zheng K.Y. HBx activates FasL and mediates HepG2 cell apoptosis through MLK3-MKK7-JNK signal module. World J. Gastroenterol. 2012, 18:1485-1495.
68. Li Y., Zhao L., Sun H., Yu J., Li N., Liang J., Wang Y., He M., Bai X., Yu Z., Zheng Z., Mi X., Wang E., Wei M. Gene silencing of FANCF potentiates the sensitivity to mitoxantrone through activation of JNK and p38 signal pathways in breast cancer cells. PLoS One 2012, 7:e44254.
69. Zhu B., Li X., Zhang Y., Ye C., Wang Y., Cai S., Huang H., Cai Y., Yeh S., Huang Z., Chen R., Tao Y., Wen X. Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells. Int. J. Cancer 2013, 132:2270-2282.
70. Jia L., Yu W., Wang P., Li J., Sanders B.G., Kline K. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells. Prostate 2008, 68:427-441.
71. Mansouri A., Ridgway L.D., Korapati A.L., Zhang Q., Tian L., Wang Y., Siddik Z.H., Mills G.B., Claret F.X. Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J. Biol. Chem. 2003, 278:19245-19256.
72. Shajahan A.N., Dobbin Z.C., Hickman F.E., Dakshanamurthy S., Clarke R. Tyrosine-phosphorylated caveolin-1 (Tyr-14) increases sensitivity to paclitaxel by inhibiting BCL2 and BCLxL proteins via c-Jun N-terminal kinase (JNK). J. Biol. Chem. 2012, 287:17682-17692.
73. Kelkel M., Cerella C., Mack F., Schneider T., Jacob C., Schumacher M., Dicato M., Diederich M. ROS-independent JNK activation and multisite phosphorylation of Bcl-2 link diallyl tetrasulfide-induced mitotic arrest to apoptosis. Carcinogenesis 2012, 33:2162-2171.
74. Song X., Kim S.Y., Lee Y.J. The role of Bcl-xL in synergistic induction ofapoptosisby mapatumumab and oxaliplatin in combination with hyperthermia on human coloncancer. Mol. Cancer Res. 2012, 10:1567-1579.
75. Malki A., El Ashry S. Quinuclidinone derivative 6 inducedapoptosisin human breastcancercells via sphingomyelinase andJNK signaling. J. Chemother. 2012, 24:268-278.
76. Zhao M., Yang M., Yang L., Yu Y., Xie M., Zhu S., Kang R., Tang D., Jiang Z., Yuan W., Wu X., Cao L. HMGB1 regulates autophagy through increasing transcriptional activities of JNK and ERK in human myeloid leukemia cells. BMB Rep. 2011, 44:601-606.
77. Sun T., Li D., Wang L., Xia L., Ma J., Guan Z., Feng G., Zhu X. C-Jun NH2-terminal kinase activation is essential for up-regulation of LC3 during ceramide-induced autophagy in human nasopharyngeal carcinoma cells. J. Transl. Med. 2011, 9:161.
78. Li C., Johnson D.E. Bortezomib induces autophagy in head and neck squamous cell carcinoma cells via JNK activation. Cancer Lett. 2012, 314:102-107.
79. Zhou F., Yang Y., Xing D. Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS J. 2011, 278:403-413.
80. Luo S., Garcia-Arencibia M., Zhao R., Puri C., Toh P.P., Sadiq O., Rubinsztein D.C. Bim inhibits autophagy by recruiting Beclin 1 to microtubules. Mol. Cell. 2012, 47:359-370.
81. Luo S., Rubinsztein D.C. BCL2L11/BIM: a novel molecular link between autophagy and apoptosis. Autophagy 2013, 9:104-105.
82. Wei Y., Sinha S., Levine B. Dual role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation. Autophagy 2008, 4:949-951.
83. Shimizu S., Konishi A., Nishida Y., Mizuta T., Nishina H., Yamamoto A., Tsujimoto Y. Involvement of JNK in the regulation of autophagic cell death. Oncogene 2010, 9:2070-2082.
84. Jung K.H., Noh J.H., Kim J.K., Eun J.W., Bae H.J., Chang Y.G., Kim M.G., Park W.S., Lee J.Y., Lee S.Y., Chu I.S., Nam S.W. Histone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent autophagic cell death in livercancer. Hepatology 2012, 56:644-657.
85. Li D.D., Wang L.L., Deng R., Tang J., Shen Y., Guo J.F., Wang Y., Xia L.P., Feng G.K., Liu Q.Q., Huang W.L., Zeng Y.X., Zhu X.F. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells. Oncogene 2009, 28:886-898.
86. Lorin S., Pierron G., Ryan K.M., Codogno P., Djavaheri-Mergny M. Evidence for the interplay between JNK and p53-DRAM signaling pathways in the regulation of autophagy. Autophagy 2010, 6:153-154.
87. Zhang X.Y., Wu X.Q., Deng R., Sun T., Feng G.K., Zhu X.F. Upregulation of sestrin 2 expression via JNK pathway activation contributes to autophagy induction in cancer cells. Cell Signal. 2013, 25:150-158.
88. Lorin S., Borges A., Ribeiro Dos Santos L., Souquère S., Pierron G., Ryan K.M., Codogno P., Djavaheri-Mergny M. c-Jun NH2-terminal kinase activation is essential for DRAM-dependent induction of autophagy and apoptosis in 2-methoxyestradiol-treated Ewing sarcoma cells. Cancer Res. 2009, 69:6924-6931.
89. Li Y., Luo Q., Yuan L., Miao C., Mu X., Xiao W., Li J., Sun T., Ma E. JNK-dependent Atg4 upregulation mediates asperphenamate derivative BBP-induced autophagy in MCF-7 cells. Toxicol. Appl. Pharmacol. 2012, 263:21-31.
90. West R.J., Sweeney S.T. Oxidative stress and autophagy: mediators of synapse growth?. Autophagy 2012, 8:284-285.
91. Haberzettl P., Hill B.G. Oxidized lipids activate autophagy in a JNK-dependent manner by stimulating the endoplasmic reticulum stress response. Redox. Biol. 2013, 1:56-64.
92. Wang Y., Singh R., Xiang Y., Czaja M.J. Macroautophagy and chaperone-mediated autophagy are required for hepatocyte resistance to oxidant stress. Hepatology 2010, 52:266-277.
93. Wyrsch P., Blenn C., Bader J., Althaus F.R. Cell death and autophagy under oxidative stress: roles of poly(ADP-Ribose) polymerases and Ca(2+). Mol. Cell. Biol. 2012, 32:3541-3553.